Examples of FDA Meeting in a sentence
FDA Meeting Notification No later than 10 business days prior to the scheduled meeting The contractor shall forward the dates and times of any meeting with the FDA to BARDA and arrange for appropriate BARDA staff to attend the FDA meetings.
FDA Meeting of the Tobacco Products Scientific Advisory Committee.
To facilitate CIRM’s participation in such meetings, Awardee shall notify CIRM as soon as practicable after it has scheduled an FDA meeting and provide to CIRM any data package(s) or other information, including confidential and/or proprietary information, prior to submission to the FDA as well as any FDA Meeting minutes.
Therefore, this particular FDA communication concerning CARDINAL’s design and washout period adequacy must have been made no later than in the January 2020 FDA Meeting.
Reata’s intent in the January 2020 FDA Meeting was to propose a quick NDA filing for FDA accelerated approval, based on the CARDINAL year-one eGFR data.
Meeting adjoured with no other business to discuss MAIL ORDER COMMITTEE CALL OCTOBER 25, 12:00 EST Present VOTING MEMBERS: Applewhite, Reyes, Auffray, Harris, Marlow, Schaffner, Thomas, Caballero, Zimmerman, WeddigPresent At-large Members: Lee, Manuel, MoretzPresent Federal Consultants: Abley (USDA), Otto (FDA) Meeting called to order by Chair Applewhite Discussion:1) Committee was reminded of CFP Anti-trust statement2) John Zimmerman made a motion to accept the minutes of the 10/11/16 call.
Immediately following the January 2020 FDA Meeting, the tone and content of the Reata Defendants’ public disclosures concerning FDA matters shifted notably.
And in August 2020, when the Reata Defendants resumed commentary on FDA-related matters, they still omitted to disclose any of the sharp substantive differences between Reata and the FDA that had surfaced in the January 2020 FDA Meeting, and instead mischaracterized FDA-Reata debates as primarily procedural ones, concerning merely the timing rather than the substance of a Bard NDA filing.
Onsite registration on the day of the hearing will be based on space availability.FDA will provide additionalbackground information at the time the Federal Register notice is published and an agenda approximately 2 weeks before the hearing at FDA Meeting Information page, which is available online at http:// www.fda.gov/Drugs/NewsEvents/ ucm398454.htm.Time will be reserved during thehearing for planned presentations from the audience.
The initial Development Plan shall be as set forth in Exhibit 2 hereto and shall (a) cover Phase II Development up to and including the End of Phase IIA FDA Meeting and any immediate follow-up Phase II Development activities directly resulting from such meeting and (b) a non-binding, high level projection of the Phase II Development activities to be undertaken thereafter.